Related Experiment Video
Updated: Sep 29, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
(+)-Tiliarine, a selective in vitro inhibitor of human melanoma cells
Tapan Seal1, Biswapati Mukherjee
1Botanical Survey of India, Indian Botanic Garden, Shibpur, Howrah 711 103, India.
Abstract:
Five diphenylbisbenzylisoquinoline (DBBI) alkaloids, tiliacorinine, tiliacorine, nor- tiliacorinine A, tiliarine and tiliamosine were isolated from the ethanol extract of the roots of Tiliacora racemosa Colebr. and identified by spectral techniques. Of these (+)-tiliarine is the only one which exhibited a selective inhibitory effect against human melanoma cells (G 361) and had no activity on normal human fibroblasts (CCD 974 SK). The activity of (+)-tiliarine against the human melanoma cell line was not much modified in the presence of calcium chloride.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Inhibition of Cdk Activity

